To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Hemolytic disease of the newborn (anti-RhE)
Hemolytic disease of the newborn (anti-RhE) is caused by the anti-RhE antibody of the Rhesus blood group system. The anti-RhE antibody can be naturally occurring, or arise following immune sensitization after a blood transfusion or pregnancy. Additional recommended knowledgeThe anti-RhE antibody is quite common especially in the Rhesus genotype CDe/CDe; it can occasionally cause mild jaundice in the neonate, but it never causes severe haemolytic disease of the newborn. It can occur with other antibodies, usually the anti-Rhc antibody, which can cause a severe hemolytic disease. References
See also
Categories: Blood disorders | Hematology | Obstetrics | Pediatrics | Transfusion medicine |
||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Hemolytic_disease_of_the_newborn_(anti-RhE)". A list of authors is available in Wikipedia. |
- New triggerable, tough hydrogels could make drug-releasing systems safer
- BU researchers design artificial genes to sense cellular responses to drugs - Understanding cell communication believed to be the key to developing new and improved medications for a wide range of health conditions.
- How the body switches out of “fight” mode - Study unlocks how cortisone inhibits inflammation
- Healthy fat? Transcription factor C/EBPβ positively influences fat storage - Will we soon be able to control the storage of excess fat?
- Finger